National and Kapodistrian University of Athens
Παθογενετικοί μηχανισμοί δυσλειτουργίας ενδοθηλίου: ο ρόλος της σιταξεντάνης στην πνευμονική ίνωση από μπλεομυκίνη σε ποντίκια
Abstract
dc:descriptionBackground: Pulmonary fibrosis is a progressive disorder leading to respiratory failure. Endothelin-1 (ET-1) is a potent vasoconstrictor, and inducer of fibrocyte and smooth muscle proliferation but its role in pulmonary fibrosis is still under investigation. We aimed to investigate the effect of highly specific ET-1 receptor A (ETA) blockade in the pathogenesis of pulmonary fibrosis. Methods: Adult male C57BL6 mice (4 groups; n=5-11/group) were injected intratracheally with bleomycin sulfate (BLM; 2mg/mL) or saline. Treatment with the highly specific ETA receptor inhibitor, sitaxentan at 15mg/kg/day through drinking water, started one day prior to BLM injection. Mice were sacrificed at day 7, 14 and 21 post BLM, after evaluation of lung mechanics. Bronchoalveolar lavage fluid (BALF), blood and lung tissue samples were obtained. Results: The BLM animal model is consistent with high mortality due to BLM exposure. This phenomenon was prevented in the Sitaxentan treated group. Additionally BLM exposure caused: i) deterioration of lung elastance and compliance, ii) lung histological injury, and iii) increased cellularity and protein content in BALF at all-time points. Highly specific ETA receptor inhibition had no effect in naive mice, while in BLM-treated mice it improved lung mechanics, attenuated lung pathology and BALF pleiocytosis at all-time points, and decreased BALF protein content at day 21. BLM increased tissue collagen deposition at day 21 from 200.5±18.7 (controls) to 294.4±29.8 µg/mL, denoting fibrosis, while sitaxentan administration managed to diminish those levels to 219.4±5.6 (Mean±SEM; p<0.05 by ANOVA). Conclusion: Prophylactic specific ETA receptor blockade preserves lung function, reduces airspace inflammation and lung pathology, and prevents collagen deposition in our model. ETA receptor inhibition may be a promising approach to the treatment of pulmonary fibrosis
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Manitsopoulos, Nikolaos
- Μανιτσόπουλος, Νικόλαος
Subjects
dc:subject × 6Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/37629